Introduction:
AMN Healthcare (NYSE:AMN) is a company that I don’t usually focus on due to its healthcare exposure, which I typically avoid for personal reasons. However, after looking at staffing agencies in other sectors, I decided to take a closer look at AMN. The company has an interesting setup that could potentially offer attractive returns for investors in the future. While there is uncertainty in the model, the good news is that the business is logically justifiable from a customer’s perspective. The decline in travel nurse demand is expected to stop at some point, and the timing of this stabilization will determine the potential returns for investors. Additionally, AMN’s language interpretation solutions segment provides some positive trends within their business. At a high share price of around $50, I personally find the risk/reward ratio not entirely comfortable, but others may see it differently.
Nurse & Allied (N&A) Segment Analysis:
AMN’s N&A segment saw a significant year-over-year increase of 35% in Q4 sales, reaching approximately $537 million. The majority of their revenue in this segment comes from Managed Service Provider (MSP) contracts, where AMN manages all the contract labor needs for their clients. Over half of their nursing sales and around 50% of Allied sales are generated through MSP contracts, indicating that over half of N&A sales come from MSP fills. The decline in travelers on assignment by 22% in Q4 and the 40% decrease in travel nursing sales were not due to a decrease in patient demand. Large hospitals like HCA Healthcare (HCA) and Tenet (THC) reported growth in patient days and admissions, respectively. The decline in demand for contract labor is attributed to hospitals shifting towards hiring more full-time employees by improving the value proposition for full-time positions. Additionally, some MSP clients are transitioning to Vendor Management Systems (VMS), which could impact AMN’s filling rates for orders.
The big question is where this trend will ultimately stabilize. It is challenging to predict, but considering the market’s need for contract labor due to temporary supply and demand constraints in hospitals, it is likely that volumes will stabilize at a level above 10K nurses on assignment. Bill rates will stabilize when demand stabilizes, and it is expected that bill rates will remain higher than 2019 levels due to inflation and increased wages in the industry.
Physician & Leadership Solution (PLS) Segment Analysis:
In Q4, PLS sales saw a marginal year-over-year increase to approximately $168 million. The segment consists of two main revenue streams, with the locum tenens business being the largest, providing temporary physicians or specialists. The future outlook for this segment looks positive, with potential for growth and opportunities.
Overall, AMN Healthcare presents an interesting investment opportunity with potential for attractive returns, despite the uncertainties in the healthcare staffing industry. Investors should consider the factors influencing the stabilization of volumes and bill rates to make informed decisions regarding their investment in the company.
Source link
